In biopharmaceutical production, the need to achieve higher productivity while maintaining quality consistency and reducing cost is the holy grail. The industry has made great progress in upstream processing in the past decade, led by improved host cell
engineering, higher expression cell lines, optimized cell culture, etc. The next decade will see smarter biomanufacturing strategies coming to the forefront, incorporating new platforms and technologies such as NGS, single cell selection, transposon,
CRISPR, data analytics, automation, PAT, digital twins, and more. The Upstream Processing conferences will dive into the many exciting trends and innovations driving the next wave of upstream development.